A 44-year-old previously healthy man with a 9-month history of progressive cognitive…
- User
A 44-year-old previously healthy man with a 9-month history of progressive cognitive decline, depression, urinary incontinence, and inability to perform tasks of daily living presented to the emergency department with worsening cognitive and neuropsychiatric symptoms. He had become more distressed, and his family noticed him departing the house without closing doors, leaving water faucets running, and sending his children to school on Sundays. History taken from the patient’s wife revealed that his brother had passed away in his late 30s after a slowly progressing functional and cognitive decline over the course of 5 years. No further detailed family history could be obtained. The review of systems was negative; he had no prior medical, psychiatric, or surgical history; and he denied any history of recent travel, camping, hiking, or vaccination. The patient was not taking any dietary supplements, nor was he taking any over-thecounter or prescription medication. Examination revealed vital signs were within normal limits. Neurocognitive assessment revealed a conscious, coherent, and alert patient with impaired memory and concentration. He showed poor attention, depressed mood, and restricted affect. He was unable to spell the word world forward, nor was he able to understand a request to spell it backward. The rest of the physical and neurologic examination revealed no abnormalities. Extensive laboratory work-up was conducted and included the following: toxicology screening; screening for HIV-1, HIV-2, and syphilis treponemal antibodies; COVID-19 polymerase chain reaction; and measurement of B1 and B12 levels. The results of screening were negative. Cerebrospinal fluid (CSF) assays, including CSF oligoclonal bands and CSF flow cytometry, revealed values within normal limits. CT of the brain without intravenous contrast material was performed in the emergency department to rule out acute intracranial abnormality (Fig 1). Multiplanar multisequence MRI of the brain without and with intravenous contrast material was ordered for further assessment (Figs 2–4). CT images of chest, abdomen, and pelvis were unremarkable (images not shown).CT of the brain without intravenous contrast material showed punctuate calcific foci with a stepping-stone appearance in the subcortical and periventricular white matter, best appreciated on sagittal reformatted images (Fig 1). MRI of the brain showed confluent white matter hyperintensities on fluid-attenuated inversion recovery images with frontal predilection that spared subcortical U fibers and involved the corpus callosum (Fig 2). Diffusion-weighted imaging revealed multiple small hyperintense lesions along the deep white matter (Fig 3) without associated contrast enhancement on T1-weighted contrast-enhanced MRI scans (Fig 4A). Brain atrophy was more pronounced in the frontal lobes and was associated with diffuse thinning of the corpus callosum (Fig 4B). On the basis of the imaging findings, a diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia was suggested. Later, the patient underwent genetic testing, which revealed a heterozygous mutation of the gene colony-stimulating factor 1 receptor (CSF1R) and served to confirm the diagnosis. What is your diagnosis?
- Assistant
Diagnosis: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) due to a heterozygous mutation in the colony-stimulating factor 1 receptor (CSF1R) gene.
Explanation:
The patient's clinical presentation, imaging findings, family history, and genetic testing are consistent with ALSP, a rare autosomal dominant neurodegenerative disorder. Here's how the information supports this diagnosis:
-
Clinical Presentation:
- Age and Symptoms: The patient is a 44-year-old man with a 9-month history of progressive cognitive decline, depression, urinary incontinence, and difficulty performing daily tasks.
- Neuropsychiatric Features: He exhibits poor attention, impaired memory and concentration, depressed mood, and restricted affect.
- Executive Dysfunction: Inability to spell the word "world" forward or understand the request to spell it backward indicates significant cognitive impairment.
- Motor Symptoms: Although not pronounced, urinary incontinence suggests dysfunction beyond purely cognitive decline.
-
Family History:
- The patient's brother died in his late 30s after a 5-year course of progressive functional and cognitive decline.
- This suggests an autosomal dominant inheritance pattern, common in ALSP due to CSF1R mutations.
-
Imaging Findings:
- CT Scan:
- Punctate Calcifications: Punctate calcific foci with a stepping-stone appearance in the subcortical and periventricular white matter are characteristic of ALSP.
- MRI Findings:
- White Matter Changes: Confluent white matter hyperintensities on FLAIR images with frontal lobe predilection.
- Sparing of Subcortical U Fibers: This pattern helps differentiate ALSP from other demyelinating diseases.
- Corpus Callosum Involvement: Involvement and thinning of the corpus callosum are notable features.
- Diffusion-Weighted Imaging (DWI): Multiple small hyperintense lesions along the deep white matter suggest active demyelination or axonal injury.
- Lack of Contrast Enhancement: Absence of enhancement indicates a lack of active inflammation or blood-brain barrier disruption.
- Brain Atrophy: Pronounced frontal lobe atrophy aligns with the cognitive and executive function deficits.
- CT Scan:
-
Laboratory Findings:
- Negative Workup: The normal laboratory tests, including infectious, metabolic, and inflammatory markers, help exclude other causes of leukoencephalopathy.
- Normal CSF Studies: Normal oligoclonal bands and flow cytometry reduce the likelihood of multiple sclerosis or central nervous system lymphoma.
-
Genetic Testing:
- CSF1R Mutation: Identification of a heterozygous mutation in the CSF1R gene confirms the diagnosis.
- Pathophysiology: CSF1R mutations lead to dysfunction in microglial cells, contributing to white matter degeneration and axonal damage.
Summary:
The combination of progressive cognitive decline in a middle-aged adult, characteristic MRI findings with frontal lobe predominance and corpus callosum involvement, a family history suggestive of an autosomal dominant pattern, and the confirmation of a CSF1R gene mutation strongly support the diagnosis of ALSP.
Implications:
- Prognosis: ALSP is progressive and currently has no cure. Early diagnosis is essential for management and genetic counseling.
- Management: Supportive care, addressing neuropsychiatric symptoms, and considering potential future therapies like bone marrow transplantation.
- Genetic Counseling: Family members may benefit from genetic testing due to the hereditary nature of the disease.
References:
- ALSP Overview: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia is a microgliopathy characterized by white matter degeneration.
- Imaging Characteristics: MRI findings often show symmetrical white matter lesions with frontal dominance, corpus callosum involvement, and relative sparing of subcortical U fibers.
- Genetic Basis: Mutations in the CSF1R gene impair microglial function, leading to the pathological features observed in ALSP.
-